Oracle’s year-to-date stock performance.
Oracle: “…I like the prospects. But you’re in it for the data center, and the data center business is excellent.”
AbbVie’s year-to-date stock performance.
AbbVie: “AbbVie is doing very, very well…My favorite in this group right now, though, remains Abbott Labs.”
Core Scientific’s year-to-date stock performance.
Core Scientific: “…It’s a mini-Palantir. So I think you should just go buy Palantir.”
Clover Health’s year-to-date stock performance.
Clover Health: “I just don’t want to go there. I know that it’s a good company, but I just don’t want to hurt anybody.”
GXO Logistics’ year-to-date stock performance.
Sweetgreen’s year-to-date stock performance.
Sweetgreen: “Sweetgreen is terrific, I really like it.”
Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.
Disclaimer The CNBC Investing Club Charitable Trust holds shares of Abbott Laboratories.
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money Twitter – Jim Cramer Twitter – Facebook – Instagram
Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com